New directions in metabolic syndrome diagnosis: assessment of vascular endothelial growth factor, pentraxin-3 and transforming growth factor beta levels
The article presents the results of Russian and international clinical studies on the levels of angiogenesis markers (vascular endothelial growth factor, pentraxin 3 and transforming growth factor beta) in patients with metabolic syndrome.
Saved in:
| Main Authors: | R. N. Shepel, O. M. Drapkina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2019-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2335 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angiogenesis in Patients with Chronic Heart Failure: Focus on Endothelial Vascular Growth Factor, Pentraxin-3 and Transforming Growth Factor Beta
by: R. N. Shepel, et al.
Published: (2020-07-01) -
Vascular endothelial growth factor facilitates the effects of telocytes on tumor cell proliferation and migration
by: Fujie Li, et al.
Published: (2024-11-01) -
Assessment of angiogenesis in children with acute lymphoblastic leukemia based on serum vascular endothelial growth factor assay
by: Agnieszka Mizia-Malarz, et al.
Published: (2017-01-01) -
Significance of vascular endothelial growth factor expression in skin melanoma
by: Gajanin Vesna, et al.
Published: (2010-01-01) -
Myocardial revascularization effects on vascular endothelial growth factor and transforming growth factor β-1 in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2007-10-01)